首页 | 本学科首页   官方微博 | 高级检索  
     


Successful Treatment of Genetically Profiled Pediatric Extranodal NK/T‐Cell Lymphoma Targeting Oncogenic STAT3 Mutation
Authors:Troy A. McEachron PhD  Ivan Kirov MD  Minkkwan Wungwattana MD  Daisy Cortes MD  Keri B. Zabokrtsky MS  Aaron Sassoon MD  PhD  David Craig PhD  John D. Carpten PhD  Leonard S. Sender MD
Affiliation:1. Integrated Cancer Genomics Division, Translational Genomics Research Institute, Phoenix, Arizona;2. Hyundai Cancer Genomics Center, Children's Hospital of Orange County, Orange, California;3. Division of Oncology, Hyundai Cancer Institute, Children's Hospital of Orange County, Orange, California;4. Pediatric Hematology/Oncology Residency Program, School of Medicine, University of California‐Irvine/Children's Hospital of Orange County, Orange, California;5. Pediatric Hematology/Oncology Fellowship Program, School of Medicine, University of California‐Irvine/Children's Hospital of Orange County, Orange, California;6. Division of Hematology‐Oncology, Department of Medicine, School of Medicine, University of California‐Irvine, Orange, California;7. Department of Pathology, Children's Hospital of Orange County, Orange, California;8. Neurogenomics Division, Translational Genomics Research Institute, Phoenix, Arizona;9. Department of Pediatrics, School of Medicine, University of California‐Irvine, Orange, California
Abstract:Extranodal natural killer (NK)/T‐cell lymphoma (ENKTCL) is a distinct type of non‐Hodgkin lymphoma predominantly observed in Asian and Latin American adult males. A 12‐year‐old Hispanic female diagnosed with ENKTCL was enrolled in our genomic profiling research protocol. We identified specific somatic alterations consistent with diagnosis of ENKTCL as well as oncogenic mutations in MAP2K1 and STAT3. To our knowledge, this is the first report of an immunophenotypically confirmed and genetically profiled case of ENKTCL in a female pediatric patient in the United States, including its unique treatment and favorable outcome.
Keywords:extranodal NK/T‐cell lymphoma  genome  STAT3
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号